Intelligent Bio Solutions INBS
NASDAQ INBS
$1.68 +0.01 (+0.60%)
As of: Oct 21, 2026 · 10:01 AM EDT

Intelligent Bio Solutions (INBS) Capital Leases (2022 - 2023)

Updated

Intelligent Bio Solutions (INBS) posted Capital Leases of $320,725 for fiscal Q3 2023 (quarter ended Mar 31, 2023), down 10.2% from the prior quarter.

Analysis

Intelligent Bio Solutions (INBS) Capital Leases (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 256.52 Bn 235.55 Bn 4.88 Bn
2 Abbott Laboratories 172.79 Bn 143.22 Bn 7.27 Bn
3 Danaher 161.75 Bn 145.55 Bn 3.61 Bn
4 Intuitive Surgical 148.25 Bn 127.68 Bn 1.96 Bn
5 Medtronic 120.30 Bn 85.55 Bn 6.34 Bn
6 Stryker 113.52 Bn 99.64 Bn 4.50 Bn
7 Boston Scientific 65.54 Bn 60.31 Bn 3.85 Bn
8 Becton Dickinson 53.28 Bn 50.43 Bn 2.32 Bn
9 Edwards Lifesciences 50.40 Bn 34.41 Bn 1.35 Bn
10 Intelligent Bio Solutions 2.47 Mn -10.78 Mn 536,583.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 320,725.00
Dec 31, 2022 357,326.00
API Access

Intelligent Bio Solutions Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=INBS&period=max&api_key=YOUR_API_KEY